EBPA-FIBROGEN INTERACTION IN ENTEROCOCCUS FAECALIS CAUTI
粪肠球菌中 EBPA-纤维原的相互作用
基本信息
- 批准号:8901925
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdhesivesAnimalsAntibiotic ResistanceAntibioticsAntibodiesAntibody ResponseBacteremiaBacteriaBacterial AdhesinsBindingBiogenesisBiological AssayBiologyBladderBladder TissueBlocking AntibodiesCathetersCessation of lifeCollaborationsDataDevelopmentDiseaseDrug FormulationsEndocarditisEnterococcus faecalisEpitheliumFibrinogenGenesGrowthHairHealthImmunityImmunizationImmunotherapyIn VitroInfectionInflammatory ResponseInterferometryKineticsLeadLigand BindingMicrobial BiofilmsModalityModelingMolecularMolecular AnalysisMusMutagenesisNosocomial InfectionsNutritional RequirementsPassive ImmunizationPathogenesisPatientsPeptide VaccinesPeptidesPilumPlatinumProliferatingProtein RegionProteinsResistanceSerumSiliconesSite-Directed MutagenesisSpecificityTestingTherapeutic AgentsThermodynamicsTubeUrethraUrinary CatheterizationUrinary tractUrinary tract infectionUrineVaccinesVirulencealternative treatmentappendagebacterial resistancebasecatheter associated UTIdirect applicationhuman diseaseimplantationin vitro Assayin vivoinsightinterdisciplinary approachmouse modelmutantnovelnovel therapeuticspreventprotective efficacy
项目摘要
DESCRIPTION (provided by applicant): Catheter-associated urinary tract infections (CAUTIs) are one of the most common nosocomial infections and if untreated can lead to serious complications including bacteremia and death. Enterococcus faecalis is a leading causative agent of CAUTI and its ability to adhere and persist within the host along with its multiple antibiotic resistances makes it difficult to prevent and treat. Furthermore, E. faecalis can form biofilm and grow despite a robust inflammatory response during CAUTI. The molecular details of how E. faecalis adheres, grows in the bladder, forms biofilm and the importance of biofilm in persistence in CAUTI are not well understood. This project will use a recently optimized model of E. faecalis CAUTI to understand how interactions between the E. faecalis Epb pilus and fibrinogen contribute to disease. Important questions to be addressed include a molecular analysis of how the EbpA subunit of the pilus binds to fibrinogen and the importance of this interaction to CAUTI. Mutants defective for biofilm formation in vitro are fully capable of forming
biofilm in murine CAUTI, suggesting that standard biofilm models do not reproduce relevant in vivo conditions. This project will evaluate a new model of fibrinogen-supplemented urine biofilms to determine if genes required for biofilm in this model are also required for biofilm in murine CAUTI and will test the importance of biofilm in causing disease. Finally, we have data to suggest that an EbpA subunit-based vaccine protects against murine CAUTI and that immunized animals generate antibody that blocks EbpA-fibrinogen binding. The project will test the protective efficacy of various EbpA sub-domain and peptide vaccines in comparison to formulations that use other pilus sub- units. Combined with passive transfers of sera from immunized animals and characterization of antibody responses, it will be possible to specifically test whether the mechanism of protection depends on blocking EbpA-fibrinogen binding. The data generated by this project will provide significant new insights into the pathogenesis of CAUTI with direct application to the development of new modalities of therapy. .
描述(由申请人提供):与导管相关的尿路感染(CAUTIS)是最常见的医院感染之一,如果未治疗,可能会导致严重的并发症,包括菌血症和死亡。肠球菌粪便是Cauti的领先病因及其在宿主中粘附和持续及其多种抗生素抗性的能力,因此难以预防和治疗。此外,尽管在小肠期间有强大的炎症反应,但粪肠球菌可以形成生物膜并生长。大肠杆菌如何粘附在膀胱中生长,形成生物膜以及生物膜在牛uti持续的重要性的分子细节尚不清楚。该项目将使用最近优化的粪肠球菌小肠模型来了解粪肠球菌EPB菌毛和纤维蛋白原之间的相互作用如何有助于疾病。要解决的重要问题包括分子分析菌毛的EBPA亚基与纤维蛋白原的结合以及这种相互作用对CAUTI的重要性。体外生物膜形成有缺陷的突变体完全能够形成
鼠类小叶中的生物膜,表明标准生物膜模型在体内条件下不会再现相关。该项目将评估纤维蛋白原补充的尿液生物膜的新模型,以确定该模型中生物膜在鼠Cauti中也需要生物膜中所需的基因,并将测试生物膜在引起疾病中的重要性。最后,我们有数据表明,基于EBPA亚基的疫苗可以保护鼠类小肠,并且免疫动物会产生阻断EBPA-纤维蛋白原结合的抗体。与使用其他Pilus子单位的制剂相比,该项目将测试各种EBPA亚域和肽疫苗的保护性疗效。结合免疫动物的血清的被动转移和抗体反应的表征,可以专门测试保护机理是否取决于阻断EBPA-纤维蛋白原结合。该项目产生的数据将为Cauti的发病机理提供重要的新见解,直接应用于新的治疗方式。 。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael G. Caparon其他文献
Streptococcus pyogenes protein F promotes invasion of HeLa cells.
化脓性链球菌蛋白 F 促进 HeLa 细胞的侵袭。
- DOI:
10.1099/00221287-144-11-3079 - 发表时间:
1998 - 期刊:
- 影响因子:1.5
- 作者:
Nobuhiko Okada;lchiro Tatsuno;Emanuel Hanski;Michael G. Caparon;C. Sasakawa - 通讯作者:
C. Sasakawa
MP23-19 FIBRINOGEN DEPOSITS ON URINARY CATHETERS IN A TIME-DEPENDENT MATTER AND CO-LOCALIZES WITH <em>E. FAECALIS</em> IN PATIENTS WITH POSITIVE <em>E. FAECALIS</em> URINE CULTURES
- DOI:
10.1016/j.juro.2017.02.747 - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Tyler M. Bauman;Aaron M. Potretzke;Ana L. Flores-Mireles;Jennifer N. Walker;Alyssa M. Park;Henry L. Schreiber;Jerome S. Pinkner;Michael G. Caparon;Scott J. Hultgren;Alana Desai - 通讯作者:
Alana Desai
Michael G. Caparon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael G. Caparon', 18)}}的其他基金
Novel Therapeutic Approach to Invasive Group A Streptococcal Disease
侵袭性 A 组链球菌疾病的新治疗方法
- 批准号:
10452033 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Novel Therapeutic Approach to Invasive Group A Streptococcal Disease
侵袭性 A 组链球菌疾病的新治疗方法
- 批准号:
10546470 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Characterization of assembly factors for type IV secretion systems
IV 型分泌系统组装因子的表征
- 批准号:
10435561 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
GmPcides: Componds that disarm antibiotic resistance in multiple gram-positive pathogens
GmPcides:解除多种革兰氏阳性病原体抗生素耐药性的化合物
- 批准号:
10577811 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
GmPcides: Componds that disarm antibiotic resistance in multiple gram-positive pathogens
GmPcides:解除多种革兰氏阳性病原体抗生素耐药性的化合物
- 批准号:
10162829 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
GmPcides: Componds that disarm antibiotic resistance in multiple gram-positive pathogens
GmPcides:解除多种革兰氏阳性病原体抗生素耐药性的化合物
- 批准号:
10352471 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Structure-function analysis of type IVB secretion systems
IVB型分泌系统的结构-功能分析
- 批准号:
10624264 - 财政年份:2019
- 资助金额:
$ 38.13万 - 项目类别:
EBPA-FIBROGEN INTERACTION IN ENTEROCOCCUS FAECALIS CAUTI
粪肠球菌中 EBPA-纤维原的相互作用
- 批准号:
9304949 - 财政年份:2014
- 资助金额:
$ 38.13万 - 项目类别:
EBPA-FIBROGEN INTERACTION IN ENTEROCOCCUS FAECALIS CAUTI
粪肠球菌中 EBPA-纤维原的相互作用
- 批准号:
8759401 - 财政年份:2014
- 资助金额:
$ 38.13万 - 项目类别:
CATABOLITE REPRESSION CONTROLS VIRULENCE IN STREPTOCOCCUS PYOGENES
分解代谢物抑制控制化脓性链球菌的毒力
- 批准号:
9174072 - 财政年份:2007
- 资助金额:
$ 38.13万 - 项目类别:
相似国自然基金
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
- 批准号:72272131
- 批准年份:2022
- 资助金额:45.00 万元
- 项目类别:面上项目
不确定性下创业团队能量和抗逆力对创业坚持的权变影响研究
- 批准号:72162025
- 批准年份:2021
- 资助金额:29 万元
- 项目类别:地区科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
- 批准号:32100850
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel therapeutics for treatment of catheter-associated UTI and depletion of the vaginal reservoir
治疗导管相关性尿路感染和阴道储库耗竭的新疗法
- 批准号:
10605022 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
2023 Microbial Adhesion and Signal Transduction Gordon Research Conferences and Seminar
2023年微生物粘附和信号转导戈登研究会议和研讨会
- 批准号:
10666171 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Reusable, transparent, and reconfigurable N95-equivalent Respirator Masks: design, fabrication, and trials for enhanced adoption
可重复使用、透明且可重新配置的 N95 等效呼吸面罩:设计、制造和试验以提高采用率
- 批准号:
10482253 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
DreamPort-Eclipse: Compact, ultra-low contact, custom fit CPAP human interface solution for obstructive sleep apnea
DreamPort-Eclipse:紧凑、超低接触、定制的 CPAP 人机界面解决方案,用于治疗阻塞性睡眠呼吸暂停
- 批准号:
10323209 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别: